Spectral-domain Optical Coherence Tomography Findings in Retinal Vessel Occlusion
NCT ID: NCT03061526
Last Updated: 2023-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2017-05-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Resolution Optical Coherence Tomography
NCT05130385
Insights From the Retina on Cerebral Microvascular Dysfunction in Haemorrhagic Stroke
NCT04363619
Retinal Thickness Analysis Using Optical Coherence Tomography
NCT00797134
Retinal Thrombosis and Atherosclerosis
NCT02257333
Spectral-domain Optical Coherence Tomography of the Eye
NCT02614625
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
optical coherence tomography
measurement of reflectivity in different retinal layers based on optical coherence tomography findings
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy contralateral eye
* examined with spectral Domain optical coherence tomography
Exclusion Criteria
* OCT Image not obtainable/missing
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technische Universität Dresden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr.med. Egbert Matthé
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Egbert Matthé, MD
Role: PRINCIPAL_INVESTIGATOR
Technical University Dresden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Eye Hospital
Dresden, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Olga Furashova
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Matthe E, Wittig D, Kuhn M, Eulitz P, Schoen K, Sandner D, Furashova O. Manual measurement of SD-OCT images of hyperreflective retinal layers in acute retinal vessel occlusion is reliable, repeatable and reproducible. Sci Rep. 2025 Oct 3;15(1):34471. doi: 10.1038/s41598-025-20086-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK 417102016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.